Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1977 2
1981 1
1982 4
1983 2
1984 2
1985 4
1986 7
1987 6
1988 4
1989 3
1990 3
1991 2
1992 4
1993 5
1994 3
1996 3
1997 2
1999 1
2000 1
2001 2
2002 2
2003 6
2004 7
2005 10
2006 9
2007 12
2008 8
2009 18
2010 16
2011 18
2012 24
2013 25
2014 21
2015 23
2016 37
2017 27
2018 29
2019 41
2020 52
2021 45
2022 63
2023 43
2024 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

574 results

Results by year

Filters applied: . Clear all
Page 1
ANCA-Associated Vasculitic Neuropathies: A Review.
Koike H, Nishi R, Ohyama K, Morozumi S, Kawagashira Y, Furukawa S, Mouri N, Fukami Y, Iijima M, Sobue G, Katsuno M. Koike H, et al. Among authors: katsuno m. Neurol Ther. 2022 Mar;11(1):21-38. doi: 10.1007/s40120-021-00315-7. Epub 2022 Jan 19. Neurol Ther. 2022. PMID: 35044596 Free PMC article. Review.
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension.
Meisel A, Annane D, Vu T, Mantegazza R, Katsuno M, Aguzzi R, Frick G, Gault L, Howard JF Jr; CHAMPION MG Study Group. Meisel A, et al. Among authors: katsuno m. J Neurol. 2023 Aug;270(8):3862-3875. doi: 10.1007/s00415-023-11699-x. Epub 2023 Apr 27. J Neurol. 2023. PMID: 37103755 Free PMC article. Clinical Trial.
Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Nishiwaki H, et al. Among authors: katsuno m. Mov Disord. 2020 Sep;35(9):1626-1635. doi: 10.1002/mds.28119. Epub 2020 Jun 18. Mov Disord. 2020. PMID: 32557853
Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence.
Vu T, Wiendl H, Katsuno M, Reddel SW, Howard JF Jr. Vu T, et al. Among authors: katsuno m. Neuropsychiatr Dis Treat. 2023 Dec 1;19:2639-2655. doi: 10.2147/NDT.S374694. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38059203 Free PMC article. Review.
Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.
Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G. Sone J, et al. Among authors: katsuno m. Brain. 2016 Dec;139(Pt 12):3170-3186. doi: 10.1093/brain/aww249. Epub 2016 Oct 25. Brain. 2016. PMID: 27797808 Free PMC article.
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.
Vu T, Meisel A, Mantegazza R, Annane D, Katsuno M, Aguzzi R, Enayetallah A, Beasley KN, Rampal N, Howard JF. Vu T, et al. Among authors: katsuno m. NEJM Evid. 2022 May;1(5):EVIDoa2100066. doi: 10.1056/EVIDoa2100066. Epub 2022 Apr 26. NEJM Evid. 2022. PMID: 38319212 Clinical Trial.
Paraproteinemia and neuropathy.
Koike H, Katsuno M. Koike H, et al. Among authors: katsuno m. Neurol Sci. 2021 Nov;42(11):4489-4501. doi: 10.1007/s10072-021-05583-7. Epub 2021 Sep 16. Neurol Sci. 2021. PMID: 34529193 Review.
574 results